De-adoption and its 43 related terms: harmonizing low-value care terminology

BMC Medicine

Adam G. Elshaug²  Danijela Gnjidic¹ 

[1] Faculty of Pharmacy, University of Sydney, Sydney, NSW, Australia;Lown Institute, Brookline, MA, USA

关键词: Medical interventions;    Low-value care;    Ineffective;    Harmful;    De-adoption;   

Others  :  1229143
DOI  :  10.1186/s12916-015-0511-4

 received in 2015-10-02, accepted in 2015-10-08,  发布年份 2015

【 摘 要 】

Research into the prevalence and impact of low-value medical practices has evolved substantially over the past two decades. However, despite international efforts, many challenges still remain with regards to progress in this field, including limits in the capacity to identify and prioritize low-value care practices and to systematically appraise clinical and policy attempts at redressing low-value care. A recent article by Niven et al. in BMC Medicine consolidates the current literature and terminology on the de-adoption of clinical practices, advocating the use of de-adoption as an appropriate term to label low-value care and proposes a new synthesis model to facilitate efforts to reverse ineffective and harmful medical practices. We hope that this work will facilitate advances in low-value care research and policy, and shift focus towards establishing evidence for de-adopting low-value interventions, which is crucial since attempts to reduce low-value care interventions have shown mixed results.

Please see related article: http://www.biomedcentral.com/1741-7015/13/255

【 授权许可】

   
2015 Gnjidic and Elshaug.

【 图 表 】

Fig. 1.

【 参考文献 】

• [1]Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? BMJ. 2011; 343:d4519.
• [2]Elshaug AG, Hiller JE, Tunis SR, Moss JR. Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007; 4:23. BioMed Central Full Text
• [3]Niven DJ, Mrklas KJ, Holodinsky JK, Straus SE, Hemmelgarn BR, Jeffs LP et al.. Towards understanding the de-adoption of low-value clinical practices: a scoping review. BMC Med. 2015; 13:255. BioMed Central Full Text
• [4]Wirtz V, Cribb A, Barber N. Reimbursement decisions in health policy-extending our understanding of the elements of decision-making. Health Policy. 2005; 73:330-8.
• [5]MacKean G, Noseworthy T, Elshaug AG, Leggett L, Littlejohns P, Berezanski J et al.. Health technology reassessment: the art of the possible. Int J Technol Assess Health Care. 2013; 29:418-23.
• [6]Morgan DJ, Brownlee S, Leppin AL, Kressin N, Dhruva SS, Levin L et al.. Setting a research agenda for medical overuse. BMJ. 2015; 351:h4534.
• [7]Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. 2013; 309:775-6.
• [8]Levinson W. Searching for effective innovations I: reducing low-value care. Webinar. Washington: Academy Health; 2015. http://www.academyhealth.org/Events/events.cfm?ItemNumber=16876. Accessed 10 Jan 2015.
• [9]Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al.. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015; 175:827-34.
• [10]Gnjidic D, Le Couteur DG, Hilmer SN. Discontinuing drug treatments. BMJ. 2014; 349:g7013.
• [11]Parkinson B, Sermet C, Clement F, Crausaz S, Godman B, Garner S et al.. Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review. Pharmacoeconomics. 2015; 33:905-24.
• [12]Paprica PA, Culyer AJ, Elshaug AG, Peffer J, Sandoval GA. From talk to action: policy stakeholders, appropriateness, and selective disinvestment. Int J Technol Assess Health Care. 2015. Ahead of print.
• [13]Wilson MG, Ellen ME, Lavis JN, Grimshaw JM, Moat KA, Shemer J et al.. Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis. Syst Rev. 2014; 3:143. BioMed Central Full Text
• [14]OECD. Geographic variations in health care: what do we know and what can be done to improve health system performance? Focus on Health. Paris: OECD; 2014. http://www. oecd.org/els/health-systems/FOCUS-on-Geographic-Variations-in-Health-Care.pdf webcite
• [15]Bhatia RS, Levinson W, Shortt S, Pendrith C, Fric-Shamji E, Kallewaard M et al.. Measuring the effect of Choosing Wisely: an integrated framework to assess campaign impact on low-value care. BMJ Qual Saf. 2015; 24:523-31.
• [16]Haas M, Hall J, Viney R, Gallego G. Breaking up is hard to do: why disinvestment in medical technology is harder than investment. Aust Health Rev. 2012; 36:148-52.
• [17]Sheingold S, Sheingold BH. Medical technology in the U.S. healthcare system: is this the road to Abilene? World Med Health Policy. 2010; 2:Article 5.